A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer
Autor: | Minion, Lindsey E., Bai, Jiaru, Monk, Bradley J., Robin Keller, L., Ramez, Eskander N., Forde, Gareth K., Chan, John K., Tewari, Krishnansu S. |
---|---|
Zdroj: | In Gynecologic Oncology June 2015 137(3):490-496 |
Databáze: | ScienceDirect |
Externí odkaz: |